Published in Biotech Business Week, October 20th, 2008
"We describe 3 patients, 2 with inflammatory bowel disease and I with myasthenia gravis, who developed febrile pustulosis consistent with Sweet syndrome 1 to 2 weeks after treatment with azathioprine. Antibiotic therapy failed In all patients, but Sweet syndrome resolved with drug withdrawal and prednisone therapy," wrote R.A. Elazhary and colleagues, Mayo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.